1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with sirolimus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boey, FY; Chatterjee, S; Kolmakova, A; Pandey, A; Tang, YD; Venkatraman, SS; Wang, XT | 1 |
1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and sirolimus
Article | Year |
---|---|
Use of a novel anti-proliferative compound coated on a biopolymer to mitigate platelet-derived growth factor-induced proliferation in human aortic smooth muscle cells: comparison with sirolimus.
Topics: Animals; Antibiotics, Antineoplastic; Aorta; Cell Proliferation; Cells, Cultured; Drug-Eluting Stents; Humans; Morpholines; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Polymers; Rabbits; Sirolimus | 2009 |